The Baker Heart and Diabetes Institute is one of the few institutes in the world where the work of our staff spans from benchtop to bedside. The Institute has more than 300 scientists, scientific support staff, clinicians, health professionals and students who work across a range of laboratories undertaking research to tackle the deadly trio of diseases: cardiovascular disease, diabetes and obesity. This multi-faced approach ensures that the Institute brings everything to bear on these challenging health issues.
Aboriginal Health | Dr Lloyd Einsiedel
Atherothrombosis and Vascular Biology | Professor Karlheinz Peter
Behavioural Epidemiology | Professor Neville Owen
Cardiac Hypertrophy | Associate Professor Julie McMullen
Clinical Diabetes and Epidemiology | Professor Jonathan Shaw
Clinical Electrophysiology | Professor Peter Kistler
Diabetes and Population Health | Professor Dianna Magliano
Experimental Cardiology | Associate Professor Xiao-Jun Du
Haematopoiesis and Leukocyte Biology | Associate Professor Andrew Murphy
Heart Failure Pharmacology | Professor Rebecca Ritchie
Heart Failure Research | Professor David Kaye
Human Autonomic Neurophysiology | Professor Vaughan Macefield
Human Neurotransmitters | Professor Murray Esler
Imaging Research | Professor Tom Marwick
Infection and Chronic Disease | Dr Lloyd Einsiedel
Lipid Metabolism and Cardiometabolic Disease | Dr Anna Calkin
Lipoproteins and Atherosclerosis | Professor Dmitri Sviridov
Metabolic and Vascular Physiology | Professor Bronwyn Kingwell
Metabolomics | Professor Peter Meikle
Molecular Metabolism and Ageing | Dr Brian Drew
Neuropharmacology | Professor Geoff Head
Oxidative Stress | Associate Professor Judy de Haan
Physical Activity | Professor David Dunstan
Preclinical Disease and Prevention | Associate Professor Melinda Carrington
Sports Cardiology | Associate Professor Andre La Gerche
Systems Epidemiology | Professor Mika Ala-Korpela
Systems Genomics | Associate Professor Michael Inouye
Vascular Biology and Atherothrombosis | Professor Alex Bobik